C. Scott McMillin | Recovery SI

Cancer, Cannabis, and the FDA

Posted by C. Scott McMillin | Nov 16, 2017 | Public Health | 0 |

The issue isn’t about getting stoned. It’s about whether the product is actually benefiting the customer who purchased it.

When he speaks, he reminds me of others I’ve known who come from families that fought and lost a battle with addictive disease.

I know how often the quest for business success has in the past overtaken and even overwhelmed the quest to deliver good services.

…healthcare advocates have to work extra hard while proponents of a more punitive approach simply point to a crime committed by a drug user…

It reminds me of the addicts who convince themselves that somehow, despite all the pain of the past, this time things will be different.